search
Back to results

Study Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG

Primary Purpose

GERD

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
laparoscopic sleeve gastrectomy
ligamentum teres cardiopexy with sleeve gastrectomy
Sponsored by
GEM Hospital & Research Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for GERD focused on measuring de Novo GERD

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • candidate for bariatric surgery according to IFSO - APC guidelines
  • No evidence (objective and subjective) of GERD

Exclusion Criteria:

  • Presence of GERD either by history or by 24 hr pH study

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Experimental

    Arm Label

    LSG

    LSG with LTC

    Arm Description

    This group will receive standard laparoscopic sleeve gastrectomy

    This group will receive LSG along with the novel LTC procedure

    Outcomes

    Primary Outcome Measures

    GERD
    Subjective (Gastroesophageal Reflux Disease questionnaires - GERD - Q) and objective (24 hour pH study) measurement of occurence of GERD will be done GERD - Q - Score 0-2 denotes no GERD. Score more than or equal to 3 indicates presence of GERD 24 hr pH study - Demeester score more than 14.7 is indicative of presence of GERD

    Secondary Outcome Measures

    Full Information

    First Posted
    November 26, 2020
    Last Updated
    December 17, 2020
    Sponsor
    GEM Hospital & Research Center
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04652336
    Brief Title
    Study Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG
    Official Title
    Randomized Controlled Trial Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2020
    Overall Recruitment Status
    Unknown status
    Study Start Date
    December 10, 2020 (Anticipated)
    Primary Completion Date
    May 10, 2021 (Anticipated)
    Study Completion Date
    December 10, 2021 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    GEM Hospital & Research Center

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The aim of this study is to investigate the effect of ligamentum teres cardiopexy on incidence of de Novo GERD.
    Detailed Description
    Laparoscopic Sleeve Gastrectomy (LSG) is now the most commonly performed bariatric surgery world wide. The results of LSG on outcomes of GERD are conflicting. It has been reported to increase the severity of pre existing GERD and also to cause new onset GERD in considerable number of patients. In this study the effect of adding a novel procedure i.e. ligamentum teres cardiopexy,(LTC) to regular LSG on occurence of de Novo GERD will be investigated. de Novo GERD has been found to occur in 20% of cases post LSG. This study is a randomized, prospective, parallel group, controlled trial to compare the effect of LSG versus LSG with LTC on occurence of de Novo GERD. This is a single center based trial, being conducted in GEM hospital and research center, Coimbatore, Tamil Nadu, India. The trial has been approved by GEM research ethics committee. Investigators are planning to enroll patients who are not having any objective or subjective evidence of GERD. The participants will be optimized as per institutional bariatric surgery protocol. After complete evaluation and optimization, participants will be randomized by computer generated random numbers into either LSG or LSG with LTC group. The demographic data, preoperative GERD - Q scores, 24 hour pH study, intra operative details will be recorded. Post operative details during each follow up will be recorded, which will include excess weight loss, GERD - Q scores. At 6 months follow up repeat 24 hour pH study will be done to assess the status of GERD objectively. The trial duration is expected to be of 1 year where in investigators will be recruiting patients for 6 months.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    GERD
    Keywords
    de Novo GERD

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    100 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    LSG
    Arm Type
    Active Comparator
    Arm Description
    This group will receive standard laparoscopic sleeve gastrectomy
    Arm Title
    LSG with LTC
    Arm Type
    Experimental
    Arm Description
    This group will receive LSG along with the novel LTC procedure
    Intervention Type
    Procedure
    Intervention Name(s)
    laparoscopic sleeve gastrectomy
    Intervention Description
    Comparator arm - will receive standard laparoscopic sleeve gastrectomy
    Intervention Type
    Procedure
    Intervention Name(s)
    ligamentum teres cardiopexy with sleeve gastrectomy
    Intervention Description
    experimental arm - Ligamentum teres will be divided from umbilicus to up to umbilical fissure. The ligament will then be wrapped around lower esophagus and sutured.
    Primary Outcome Measure Information:
    Title
    GERD
    Description
    Subjective (Gastroesophageal Reflux Disease questionnaires - GERD - Q) and objective (24 hour pH study) measurement of occurence of GERD will be done GERD - Q - Score 0-2 denotes no GERD. Score more than or equal to 3 indicates presence of GERD 24 hr pH study - Demeester score more than 14.7 is indicative of presence of GERD
    Time Frame
    6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: candidate for bariatric surgery according to IFSO - APC guidelines No evidence (objective and subjective) of GERD Exclusion Criteria: Presence of GERD either by history or by 24 hr pH study
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    PRAKHAR GUPTA
    Phone
    +919582438389
    Email
    mailto.guptaprakhar@gmail.com

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Study Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG

    We'll reach out to this number within 24 hrs